Rebate
walls may thwart biosimilar savings
|
|
Humira
biosimilars are expected to reduce annual pharmaceutical expenditures by $5
billion, but they may be delayed by rebate strategies. |
Rebate
walls may thwart biosimilar savings
|
|
Humira
biosimilars are expected to reduce annual pharmaceutical expenditures by $5
billion, but they may be delayed by rebate strategies. |
No comments:
Post a Comment